Decreased Gait and Function in Duchenne Muscular Dystrophy

DOI: 10.4236/ojtr.2014.23017   PDF   HTML     5,000 Downloads   5,887 Views   Citations


Duchenne muscular dystrophy (DMD) is a genetic disorder linked to chromosome Xp21, due to absence of dystrophin production. It is clinically characterized by progressive muscle weakness, fatigue, and development of joint contractures that compromise general motor functionality, mainly the gait. Objective: To characterize the motor function and decrease gait in children with DMD using the Portuguese version of the Motor Function Measure scale (MFM-P). Methods: A review of medical records including chronological age and scores from MFM-P of children with a DMD who attended at the Neuromuscular Diseases Clinic at Campinas State University (UNICAMP), Brazil was performed in this study. A total of 36 medical records of male patients with confirmed clinical diagnosis of DMD, ambulatory or not, regardless of age; excluding those with other associated diseases or other types of muscular dystrophies were selected. Data were analyzed using Kolmogorov-Smirnov and Spearman correlation statistical tests. Results: Analysis of all data collected showed that 75% of our sample had D1 scores lower than 41.02%. There was a linear relationship between the scores of D2 and D3, but no association between D2 and D1 scores was noted. D1 score was between 40% and 80% in those patients presenting D2 scores between 80% and 100%. In all cases patients with low total score presented a greater risk for loss of gait and their functionality. Conclusion: The standing posture and the postural transfers were the worst activities observed in children with DMD, with positive correlation between proximal and distal motor function. Even with high scores according MFM-P in proximal function, the children showed strong predictors for loss of gait.

Share and Cite:

Cristina Iwabe-Marchese, C. , Fávaro, A. and Luiz, L. (2014) Decreased Gait and Function in Duchenne Muscular Dystrophy. Open Journal of Therapy and Rehabilitation, 2, 120-125. doi: 10.4236/ojtr.2014.23017.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Fernandes, L.A.Y., Caromano, F.A., Hukuda, M.E., Escorcio, R. and Carvalho, E.V. (2010) Development and Reliability of the Functional Scale Going up and down Stairs for Muscular Dystrophy. Revista Brasileira de Fisioterapia, 14, 518-526.
[2] Araújo, A.P.Q.C., Deco, M.C., Kloh, B.S., Costa, M.R., Gois, F.V. and Guimarães, F.H.H. (2004) Delay in Diagnosis of Duchenne Muscular Dystrophy. Revista Saúde Materno Infantil, 4, 179-183.
[3] Gomes, A.L.O., Pinto, A.N., Goes, E.R., Hirosue, L.N., Peixoto, B.O., Caromano, F.A. and Blascovi Assis, S.M. (2011) Motor and Functional Performance in Duchenne Muscular Dystrophy: A Case Report. Journal of the Health Sciences Institute, 29, 131-135.
[4] Escorcio, R., Caromano, F.A., Hukuda, M.E. and Fernandes, L.A.Y. (2011) Development of an Evaluation Scale for Sitting and Standing from the Ground for Children with Duchenne Muscular Dystrophy. Journal of Motor Behavior, 43, 37-41.
[5] D’Angelo, M.G., Berti, M., Piccinini, L., Romei, M., Guglieri, M., Bonato, S., Degrate, A., Turconi, A.C. and Bresolin, N. (2009) Gait Pattern in Duchenne Muscular Dystrophy. Gait & Posture, 29, 36-41.
[6] Melanda, A.G., Pauleto, A.C., Knaut, L.A., Ferreira, A.E.K., Iucksch, D.D., Silva, R.M. and Cunha, R.F.M. (2011) Evaluation of Patients with Duchenne Muscular Dystrophy Laboratory Computerized Index March through the Amendment of the March. Revista Brasileira de Ortopedia, 46, 10-13.
[7] Beenakker, E.A.C., Maurits, N.M., Fock, J.M., Brouwer, O.F. and Hoeven, J.H.V.D. (2005) Functional Ability and Muscle Force in Healthy Children and Ambulant Duchenne Muscular Dystrophy Patients. European Journal of Paediatric Neurology, 9, 387-393.
[8] Bérard, C., Payan, C. and Hodgkinson, I.J. (2005) The Fermanian Motor Function Measure Scale for Neuromuscular Diseases. Construction and Validation Study. Neuromuscular Disorders, 15, 463-470.
[9] Iwabe, C., Miranda-Pfeilsticker, B.H. and Nucci, A. (2008) Motor Function Measure Scale: English Version and Reliability Analysis. Revista Brasileira de Fisioterapia, 12, 417-424.
[10] Jeannet, P.Y., Aminian, K., Bloetzer, C., Najafi, B. and Paraschiv-Ionescu, A. (2011) Continuous Monitoring and Quantification of Multiple Parameters of Daily Physical Activity in Ambulatory Duchenne Muscular Dystrophy Patients. European Journal of Paediatric Neurology, 15, 40-47.
[11] Bushby, K., Finkel, R., Birnkrant, D.J., Case, L.E., Clemens, P.R., Cripe, L., et al. (2010) Diagnosis and Management of Duchenne Muscular Dystrophy, Part 1: Diagnosis, and Pharmacological and Psychosocial Management. Lancet Neurology, 9, 77-93.
[12] Conover, J.W. (1971) Practical Nonparametric Statistics. John Wiley & Sons, New York, 295-301,309-314.
[13] Vuillerot, C., Girardot, F., Payan, C., Iwaz, J., De Lattre, C. and Berard, C. (2009) Monitoring Changes and Predicting Loss of Ambulation in Duchenne Muscular Dystrophy with the Motor Function Measure. Developmental Medicine & Child Neurology, 52, 60-65.
[14] Chaustre, D.M. and Willington, C.S. (2011) Duchenne Muscular Dystrophy. Prospects of Rehabilitation. Review Article. Rev. Fac Med, 19, 37-44.
[15] Ganea, R., Jeannet, P.Y., Ionescu, A.P., Goemans, N.M., Piot, C., Den Hauwe, M.V. and Aminian, K. (2012) Gait Assessment in Children with Duchenne Muscular Dystrophy during Long-Distance Walking. Journal of Child Neurology, 27, 30-38.
[16] Fischmann, A., Hafner, P., Gloor, M., Schmid, M., Klein, A., Pohlman, U., et al. (2013) Quantitative MRI and Loss of Free Ambulation in Duchenne Muscular Dystrophy. Journal of Neurology, 260, 969-974.
[17] Da Silva, E.C., Machado, D.L., Resende, M.B.D., Silva, R.F., Zanoteli, E. and Reed, U.C. (2012) Scale Measure of Motor Function, Steroid Therapy, and Patients with Duchenne Muscular Dystrophy. Arquivos de Neuro-Psiquiatria, 70, 191-195.
[18] Santos, N.M., Rao, M.M., Terni, A., Hayashi, M.C.B., Fávero, F.M., Tables, A.A.J., et al. (2006) Clinical and Functional Profile of Patients with Duchenne Muscular Dystrophy Assisted in Brazilian Muscular Dystrophy Association (ABDIM). Reviews in the Neurosciences, 14, 15-22.
[19] McDonald, C.M., Henricson, E.K., Han, J.J., Abresch, R.T., Nicorici, A., Elfring, G.L., Atkinson, L., Reha, A., Hirawat, S. and Miller, L.L. (2009) The 6-Minute Walk Test as a New Outcome Measure in Duchenne Muscular Dystrophy. PTC Therapeutics, 100 Corporate Court, South Plainfield, New Jersey.
[20] Bakker, J.P.J., de Groot, I.J.M., Beelen, A. and Lankhorst, G.J. (2002) Predictive Factors of Cessation of Ambulation in Patients with Duchenne Muscular Dystrophy. American Journal of Physical Medicine & Rehabilitation, 81, 906-912.
[21] Zanoteli, E. (2014) Predicting the Loss of Ambulation in Duchenne Muscular Dystrophy. Arquivos de Neuro-Psiquiatria, 72, 1-2.
[22] Martini, J., Voos, M.C., Hukuda, M.E., Resende, M.B.D. and Caromano, F.A. (2014) Compensatory Movements during Functional Activities in Ambulatory Children with Duchenne Muscular Dystrophy. Arquivos de Neuro-Psiquiatria, 72, 5-11.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.